CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC

1:16-cv-00377

Overview

Case Number 1:16-cv-00377
Filing Date 2016-05-20
Status Terminated
Termination Date 2016-06-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1331 Fed. Question
Jury Demand None

Parties

Defendant

Glaxo Group Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

GlaxoSmithKline LLC NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Lotus Pharmaceutical Co. Ltd Operating Company

Represented By

3 Attorneys Listed

Stephen M. Hash

Email: stephen.hash@bakerbotts.com

Shannon M. Kidd

Email: shannon.kidd@bakerbotts.com

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): GB πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2018-09-28
1:18-cv-01513

Alembic Pharmaceuticals Limited v. GlaxoSmithKline LLC

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8637512
Formulations and method of treatment
Filed: 2003-12-02
Issued: 2014-01-28
Active (2.1 yrs remaining) +1863d PTA
Expires: 2029-01-07
US9144547
Oral dosage form for controlled drug release
Filed: 2010-12-13
Issued: 2015-09-29
Expired (Term Ended)
Expires: 2023-09-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1863 days) / Cellect Scrutiny β€” Over 1863 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(17 total)
Pleading / Complaint

COMPLAINT FOR DECLARATORY JUDGMENT filed against Glaxo Group Limited, GlaxoSmithKline LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1934980.) - filed by Lotus Pharmaceutical Co. Ltd.(Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(aah) (Entered: 05/23/2016)

Entry #1 • 2016-05-20
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction.(aah) (Entered: 05/23/2016)

Entry #2 • 2016-05-20
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,637,512; 9,144,547;(aah) (Entered: 05/23/2016)

Entry #3 • 2016-05-20
1

Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alvogen Asia Pacific Holdings Ltd. for Lotus Pharmaceutical Co. Ltd filed by Lotus Pharmaceutical Co. Ltd. (Gattuso, Dominick) (Entered: 05/23/2016)

Entry #4 • 2016-05-23
1

Summons Issued with Magistrate Consent Notice attached as to GlaxoSmithKline LLC. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them.(aah)

Entry #5 • 2016-05-23
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc